It is not often that litigation funding makes the national, let alone international news, but the recent allegations made by Muddy Waters in respect of Burford Capital’s accounting practices have even captured the interest of many mainstream media outlets. Whether the accusations stem from a lack of understanding about the risks involved in this incredibly niche market, or whether they have substance, is for investment analysts and the investment community to debate. But we can be sure that headlines such as these will always attract scrutiny by those looking for reasons to denounce litigation funding. Such detractors will link any negative news about the industry to the need for regulation and greater oversight. Continue reading

REUTERS | Mohamad Torokman
August 30, 2019
Will the Burford/Muddy Waters saga increase the likelihood of regulation for the litigation funding industry?

REUTERS | Gregg Newton
Here I look at two recent and helpful publications, and given the source of those publications, those are slightly surprising words from me! Continue reading

REUTERS | Louafi Larbi
August 22, 2019
Nothing to speak of: when silence is golden after Woodward v Phoenix Healthcare Distribution
Background
The underlying dispute in Woodward and another v Phoenix Healthcare Distribution Ltd concerned the alleged mis-sale of a drug by the respondent whilst still under patent to a company which claimed that, as a result of the respondent’s breach of contract or misrepresentations, it suffered financial loss in excess of £5 million and which forced it to enter administration. Continue reading